Zhanling International LTD 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
Zhanling International Limited's annual report highlights a lack of revenue, a significant net loss, and a working capital deficiency, raising substantial doubt about its ability to continue as a going concern.
OTC.Pink
Zhanling International Limited reported no revenue and increased net losses for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern.
OTC.Pink
10-KT: Zhanling International Limited Reports Financial Results for Transition Period Ended May 31, 2024
Zhanling International Limited, a development-stage company, reported its financial results for the five-month transition period ended May 31, 2024, showing no revenue and a net loss.
OTC.Pink
Zhanling International Limited, formerly Odenza Corp., released its annual report for the fiscal year ended December 31, 2023, highlighting a year of significant leadership and ownership transitions alongside ongoing efforts to identify a suitable business combination target.